Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Discussion In this phase 1, randomised, placebo-controlled, double-blind study in overweight or obese participants with type 2 diabetes, the primary endpoint of Part A was met, but only one of the two co-primary endpoints in Part B was met
Yesthe PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR and FTO, and MC4R variants to identify your metabolic phenotype and side-effect risk profile
Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study
Signs include dizziness, sweating, shakiness, and confusion
US$ 26.45
US$ 27.29
US$ 20.86
US$ 26.25
US$ 25.39
US$ 27.31
US$ 24.65
US$ 21.86
